4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-049873
Chief Financial Officer sold 20,000 shares at $36.17 ($723,400)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-09-08 | Option exercise | +20,000 | $6.32 | $126,400 | 21,000 | D |
| Cohen Chad M Chief Financial Officer | 2020-09-08 | Sale | −20,000 | $36.17 | $723,400 | 1,000 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2020-09-08 | Option exercise · Stock Option (Right To Buy) | −20,000 | 590,000 | D | ||
| Open-market sales · 20,000 sh · avg $36.17 · $723,400 | |||||||
Loading xslF345X03/doc4.xml…